PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.417
https://www.valueinhealthjournal.com/article/S1098-3015(11)01979-6/fulltext
Title :
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01979-6&doi=10.1016/j.jval.2011.08.417
First page :
A307
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
388